Tihomir Z.
- Country
- Bulgaria
- Department
- Third Department of Clinical Hematology to Clinic of Clinical Hematology
Research Overview
Data & Insights
Has run more than one trial at 14 of 73 partner sites.
Specializations
Hematologic Disorders
The investigator specializes in treating various forms of myelofibrosis, a serious bone marrow disorder that affects blood cell production.
- Primary Myelofibrosis
- Post-Polycythemia Vera Myelofibrosis
- Post-Essential Thrombocythemia Myelofibrosis
Their work focuses on innovative therapeutic approaches for managing these challenging blood disorders.
Treatment Innovation
The investigator explores novel therapeutic agents including pacritinib and momelotinib for treating myelofibrosis patients.
- Advanced Treatment Protocols
- Long-term Disease Management
- Extended Access Programs
Their research emphasizes improving treatment outcomes for patients with various forms of myelofibrosis.
Clinical Outcomes
The investigator evaluates treatment effectiveness through specific clinical markers including spleen volume reduction and symptom score improvement.
- Disease Progression Assessment
- Therapeutic Response Monitoring
- Long-term Safety Evaluation
Their work includes comprehensive assessment of patient responses to various therapeutic interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.